Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675722 · ClinicalTrials.gov registry record · Phase 1
Implantation Of Vaginal Construct For Patients With Vaginal Aplasia
A Phase 1 study of Congenital Mullerian Duct Anomaly, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05675722: Recruiting Phase 1 study of Congenital Mullerian Duct Anomaly, sponsored by Wake Forest University Health Sciences.
NCT05675722 is a Phase 1 study of Congenital Mullerian Duct Anomaly that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05675722, a Phase 1 study of Congenital Mullerian Duct Anomaly, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
In this Phase 1, single site, clinical trial, Vulvar/vaginal Smooth muscle cells (SMC) and Epithelial Cells (EPC) are isolated from autologous patient's biopsy
Primary Outcome
bleeding, pain, visceral injury, vaginal scarring, contraction, or infection
Conditions Studied
Interventions
- BIOLOGICAL biologic vaginal-construct implantation
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2029-12 |
| Phase | Phase 1 |
What NCT05675722 shows while recruiting
NCT05675722 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Congenital Mullerian Duct Anomaly appearing as the primary indexed condition, and to 1 intervention - of which biologic vaginal-construct implantation is the first listed.
NCT05675722 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05675722 about?
NCT05675722 is a clinical study titled "Implantation Of Vaginal Construct For Patients With Vaginal Aplasia". In this Phase 1, single site, clinical trial, Vulvar/vaginal Smooth muscle cells (SMC) and Epithelial Cells (EPC) are isolated from autologous patient's biopsy
What is the current status of trial NCT05675722?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2023-06-01. Estimated completion is 2029-12.
What conditions does trial NCT05675722 study?
This clinical trial studies the following conditions: Congenital Mullerian Duct Anomaly.
What interventions are being tested in trial NCT05675722?
The interventions under investigation include: biologic vaginal-construct implantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT05675722?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05675722 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05675722's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI